Christopher Sarchi
Corporate Officer/Principal chez REPLIMUNE GROUP, INC.
Fortune : 830 268 $ au 30/06/2024
Postes actifs de Christopher Sarchi
Sociétés | Poste | Début | Fin |
---|---|---|---|
REPLIMUNE GROUP, INC. | Corporate Officer/Principal | 03/01/2023 | - |
Historique de carrière de Christopher Sarchi
Anciens postes connus de Christopher Sarchi
Sociétés | Poste | Début | Fin |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2010 | 01/01/2013 |
SANOFI | Corporate Officer/Principal | - | - |
Formation de Christopher Sarchi
University of Maine | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
France | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
REPLIMUNE GROUP, INC. | Health Technology |
SANOFI | Health Technology |
Entreprise privées | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Christopher Sarchi
- Expérience